MET · MetLife, Inc.
$97.14
+0.37% last session
End-of-day data · close of 2026-09-11
Market cap
$62B
Enterprise value
$85B
Trailing P/E
18.5
Forward P/E
8.9
Dividend yield
2.0%
Beta
0.76
Avg volume
4M
Employees
46K
Daily Change %
0.37%
5 Days Change
-1.98%
10 Days Change
0.55%
30 Days Change
-1.15%
60 Days Change
5.05%
Month to Day Change
1.35%
Year to Day Change
23.79%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — MET
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-24
Latest call per bank · past 12 months
Morgan Stanley
Overweight$111
+14.7% vs priceWells Fargo
Overweight$109
+12.6% vs priceJP Morgan
Overweight$108
+11.6% vs priceBarclays
Overweight$97.00
+0.2% vs priceJefferies
Buy$103
+6.4% vs priceUBS
Buy$105
+8.5% vs priceBank of America
Buy$99.00
+2.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-24 | Morgan Stanley | Maintains | Overweight | $103 → $111 |
| 2026-08-19 | Wells Fargo | Maintains | Overweight | $101 → $109 |
| 2026-08-11 | JP Morgan | Maintains | Overweight | $106 → $108 |
| 2026-08-11 | Keefe, Bruyette & Woods | Maintains | Outperform | $105 → $108 |
| 2026-08-06 | Barclays | Maintains | Overweight | $94.00 → $97.00 |
| 2026-07-22 | TD Cowen | Maintains | Buy | $87.00 → $105 |
| 2026-07-21 | JP Morgan | Maintains | Overweight | $96.00 → $106 |
| 2026-07-13 | Evercore ISI Group | Maintains | In-Line | $96.00 → $103 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 55 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 2.4% above the 50-day MA ($94.91).
- Price vs 200-day MA: Trading 19.2% above the 200-day MA ($81.50).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.09) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($99.95).
MET Price Chart
Loading chart for MET…
Fundamentals
About MetLife, Inc.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.
More in Insurance - Life
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.